Prenatal screening tied to earlier surgery for congenital heart disease in younger babies: Circulation

Written By :  Dr. Kamal Kant Kohli
Published On 2023-08-09 01:15 GMT   |   Update On 2023-08-09 05:52 GMT

USA: A recent study published in the journal Circulation: Cardiovascular Quality and Outcomes has shed light on the association between prenatal diagnosis and age at surgery for critical and noncritical congenital heart defects (CHDs). Congenital heart defects are the most common birth defects affecting nearly 1% of all live births. The study from Ann & Robert H. Lurie Children’s...

Login or Register to read the full article

USA: A recent study published in the journal Circulation: Cardiovascular Quality and Outcomes has shed light on the association between prenatal diagnosis and age at surgery for critical and noncritical congenital heart defects (CHDs). Congenital heart defects are the most common birth defects affecting nearly 1% of all live births. 

The study from Ann & Robert H. Lurie Children’s Hospital of Chicago found that younger age at CHD surgery, which was associated with postsurgical physical and neurodevelopmental outcomes, is significantly associated with prenatal CHD diagnosis, or diagnosis before a baby is born. The association was demonstrated for critical defects (when heart surgery is required before the infant leaves the hospital) and certain types of noncritical defects, which constitute about 75% of all congenital heart defects.

The benefits of prenatal diagnosis of congenital heart defects for babies have been debated. With the knowledge that earlier heart surgery is often better for a child’s development, investigators at Lurie Children’s have found that prenatally diagnosed babies born with critical heart disease had surgery on average one week sooner than those with postnatal diagnosis. Surgery for babies with prenatally diagnosed noncritical cardiac defects occurred anywhere from two to 12 months sooner. 

“Our study quantifies the tremendous importance of prenatal diagnosis for infants with congenital heart disease,” said lead author Joyce Woo, MD, MS, a cardiologist at Lurie Children’s and Assistant Professor of Pediatrics and Medical Social Sciences at Northwestern University Feinberg School of Medicine. “For infants with critical disease especially, getting surgery a week earlier can make a big difference in the development of the brain and other organs. Earlier surgery for certain types of noncritical congenital heart disease can also prevent poor outcomes, such as heart failure. Our findings emphasize that prenatal diagnosis is crucial to optimize surgical timing and the long-term health of the baby. Prenatal diagnosis needs to be equitably accessible to all pregnant people.”

Dr. Woo and colleagues analyzed a cohort of 1,131 patients with congenital heart defects, aged 0-9 years, who received their initial cardiac surgery at Lurie Children’s between 2015 and 2021. Nearly half of these patients had prenatal diagnosis. After accounting for demographics, comorbidities and surgical complexity, the average age at surgery was significantly younger in infants with prenatally versus postnatally diagnosed critical and noncritical congenital heart disease. Infants with one of the most common types of noncritical disease, called atrial septal defects, had surgery about a year sooner.

“Our study shows that the best care for kids starts with prenatal diagnosis. More research is needed to identify and overcome the barriers to prenatal diagnosis,” said Dr. Woo. “These can include social barriers such as distance to care, lack of childcare, or inability to take time off from work. We need a better understanding of these factors in order to provide the highest quality care to babies born with cardiac defects, and their families.”

Reference:

Woo JL, et al "Association between prenatal diagnosis and age at surgery for noncritical and critical congenital heart defects" Circ Cardiovasc Qual Outcomes 2023; DOI: 10.1161/CIRCOUTCOMES.122009638.

Tags:    
Article Source : Circulation Cardiovascular Quality and Outcomes

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News